[go: up one dir, main page]

MX9300409A - Hexahidroazepinonas y tetrahidrobenzoazepinonas sustituidas. - Google Patents

Hexahidroazepinonas y tetrahidrobenzoazepinonas sustituidas.

Info

Publication number
MX9300409A
MX9300409A MX9300409A MX9300409A MX9300409A MX 9300409 A MX9300409 A MX 9300409A MX 9300409 A MX9300409 A MX 9300409A MX 9300409 A MX9300409 A MX 9300409A MX 9300409 A MX9300409 A MX 9300409A
Authority
MX
Mexico
Prior art keywords
substituted
tetrahidrobenzoazepinonas
hexahidroazepinonas
tetrahydrobenzoazepinones
haxahydroazepinones
Prior art date
Application number
MX9300409A
Other languages
English (en)
Inventor
John A Lowe Iii
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of MX9300409A publication Critical patent/MX9300409A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06139—Dipeptides with the first amino acid being heterocyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/16—Benzazepines; Hydrogenated benzazepines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Esta invención se refiere a nuevas haxahidroazepinonas y tetrahidrobenzoazepinonas sustituidas estos compuestos son útiles en el tratamiento y preparación de los trastornos gastrointestinales, el dolor y los trastornos de ansiedad.
MX9300409A 1992-01-27 1993-01-26 Hexahidroazepinonas y tetrahidrobenzoazepinonas sustituidas. MX9300409A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US82567792A 1992-01-27 1992-01-27

Publications (1)

Publication Number Publication Date
MX9300409A true MX9300409A (es) 1993-07-01

Family

ID=25244657

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9300409A MX9300409A (es) 1992-01-27 1993-01-26 Hexahidroazepinonas y tetrahidrobenzoazepinonas sustituidas.

Country Status (19)

Country Link
EP (1) EP0625145A1 (es)
JP (1) JPH07503465A (es)
KR (1) KR950700257A (es)
CN (1) CN1074903A (es)
AU (1) AU3276193A (es)
BR (1) BR9207071A (es)
CA (1) CA2117367A1 (es)
CZ (1) CZ391092A3 (es)
FI (1) FI943513A0 (es)
HU (1) HUT70496A (es)
IL (1) IL104472A0 (es)
MX (1) MX9300409A (es)
NO (1) NO942775L (es)
NZ (1) NZ245759A (es)
RU (1) RU94038063A (es)
TW (1) TW213901B (es)
WO (1) WO1993015059A1 (es)
YU (1) YU4393A (es)
ZA (1) ZA93582B (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2097688A1 (es) * 1993-07-14 1997-04-01 Pfizer Hexahidroazepinonas y tetrahidrobenzazepinonas sustituidas.
CA2168131C (en) * 1993-07-26 1998-10-06 John A. Lowe, Iii Tetrahydro-1h-benzazepinones containing acid surrogates
EP0730581B1 (en) * 1993-11-22 2001-10-04 Merck & Co. Inc. 3-acylaminobenzazepines
US5453424A (en) * 1993-11-22 1995-09-26 Merck & Co., Inc. Furanodiazepines
US5977355A (en) * 1994-10-04 1999-11-02 Pfizer Inc. Processes and intermediates for preparing 3-amino-benzo(b)azepinones
IL115589A0 (en) * 1994-10-14 1996-01-19 Glaxo Spa Use of cck-b antagonists in pharmaceutical compositions
DE10153348A1 (de) * 2001-10-29 2003-05-08 Gruenenthal Gmbh Substituierte Benzo(b)azepin-2-on-Verbindungen
RU2415132C2 (ru) * 2005-06-16 2011-03-27 Новартис Аг Производные оксоазепанилацетамида и оксоазепанилфеноксиацетамида, содержащие их композиции и способы, предназначенные для ингибирования репликации вируса гепатита с (hcv)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0166357A3 (en) * 1984-06-26 1988-10-26 Merck & Co. Inc. Benzofused lactams and pharmaceutical compositions containing them
US4767756A (en) * 1987-07-17 1988-08-30 E. R. Squibb & Sons, Inc. 3-substituted benzazepines
EP0322779A3 (en) * 1987-12-29 1991-05-08 Yoshitomi Pharmaceutical Industries, Ltd. Benzolactam compounds and pharmaceutical uses thereof
US5206234A (en) * 1990-10-22 1993-04-27 Merck & Co., Inc. Benzolactam analogs as antagonists of cck

Also Published As

Publication number Publication date
CN1074903A (zh) 1993-08-04
HUT70496A (en) 1995-10-30
EP0625145A1 (en) 1994-11-23
FI943513A7 (fi) 1994-07-26
WO1993015059A1 (en) 1993-08-05
FI943513L (fi) 1994-07-26
ZA93582B (en) 1994-07-27
TW213901B (es) 1993-10-01
CZ391092A3 (en) 1994-01-19
CA2117367A1 (en) 1993-08-05
IL104472A0 (en) 1993-05-13
RU94038063A (ru) 1996-05-27
AU3276193A (en) 1993-09-01
KR950700257A (ko) 1995-01-16
NO942775L (no) 1994-09-20
BR9207071A (pt) 1995-12-05
FI943513A0 (fi) 1994-07-26
YU4393A (sr) 1996-01-09
NZ245759A (en) 1997-06-24
JPH07503465A (ja) 1995-04-13
NO942775D0 (no) 1994-07-26
HU9402195D0 (en) 1994-09-28

Similar Documents

Publication Publication Date Title
ES2116594T3 (es) Ansamicinas biciclicas y su uso como agentes antitumorales.
ATE120957T1 (de) Formulierungen von tetrazyklinverbindungen mit kontrollierter freisetzung.
DK20892D0 (da) Seksuelt hjaelpemiddel
MX9301634A (es) Quinuclidinas peptidicas.
LV5824B4 (lv) Cilveku psihozes arstesanas panemiens
MY111201A (en) New imidazopyridines
KR890700313A (ko) 살균 조성물
MX9205219A (es) Un material de n-oxido de tramadol, enantiomeros, y composiciones del mismo, y su uso
ES2157992T3 (es) Alcoxi-alquil-carbamatos de imidazo(1,2-a)piridinas.
FI945085L (fi) Yhdistelmä-neu-reseptoristimulaatiotekijä
FI930621A0 (fi) Bifenylsubstituerade kinolinderivat
MX9300409A (es) Hexahidroazepinonas y tetrahidrobenzoazepinonas sustituidas.
NO903148L (no) Hemoreguleringspeptider.
FI891986A7 (fi) Farmaseuttiset koostumukset psoriasiksen hoitoon
ITMI913465A0 (it) Procedimento per la depurazione dell'1.1.1-trifluoro-2-fuoroetano
DK0545582T3 (da) Forbedret fiskeproduktion
ES2012314A4 (es) Tratamiento de composiciones precursoras de poliamida.
DK87888D0 (da) Terapeutisk anvendelse af tindijoddeuteroporfyrin
NO982562D0 (no) Sammensetning for behandling av smerte
ES2056876T3 (es) Compuestos piperidinilicos 1,4-disustituidos.
FI890810A7 (fi) Palovammojen käsittely
DK0967986T3 (da) Anvendelse af humant alfa1-surt glycoprotein til fremstilling af et farmaceutisk præparat
ES2167942T3 (es) Empleo de 2-aminotetralinas 6,7-sustituidas apropiadas para la preparacion de una composicion farmaceutica para el tratamiento terapeutico de patologias inflamatorias y/o autoinmunes.
FR2566265B1 (fr) Bague d'extension phallique
ITMI910967V0 (it) Regolo per la determinazione dell'intensita' del dolore